Mangoceuticals (MGRX) Interest Expenses (2022 - 2026)

Mangoceuticals (MGRX) has 5 years of Interest Expenses data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses changed 0.0% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed 0.0% YoY), and the FY2025 full-year result was $8.5 million, up 110.61% from the prior year.
• Interest Expenses improved to $1.1 million in Q1 2026, from $19663.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $8.8 million in Q3 2025 to a low of $19663.0 in Q4 2025.
• A 5-year average of $1.6 million and a median of $760281.0 in 2024 frame the typical range for Interest Expenses.
• Peak annual rise in Interest Expenses reached 10150.01% in 2025, while the deepest fall reached 99.51% in 2025.
• Tracing MGRX's Interest Expenses over 5 years: stood at $2.0 million in 2022, then sank by 68.24% to $640194.0 in 2023, then surged by 530.17% to $4.0 million in 2024, then sank by 99.51% to $19663.0 in 2025, then soared by 5609.4% to $1.1 million in 2026.
• Business Quant data shows MGRX's Interest Expenses at $1.1 million in Q1 2026, $19663.0 in Q4 2025, and $8.8 million in Q3 2025.